"Phase 2 RCT: Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain." NCT07437547
Multiple rodent studies have demonstrated that BPC 157 administration both locally and systemically reduces markers of gastric damage, accelerates mucosal healing in ulcer models, and appears to counteract the damage caused by NSAIDs and corticosteroids
A List of Product Categories Offered by Apikos Pharma Tablets Capsules Injections Ontiments Softgels Powder Ointment Dental Protein Powder Sachets Pediatric Range NuROKIND Injection Mankind Pharma Ltd NuROKIND Injection by Mankind Pharma has built strong trust among clinicians due to its proven neurological benefits
Intended Use: For laboratory research use only Key Characteristics of BPC-157 (10 mg) Supplied as a high-purity, lyophilized research peptide Defined amino acid sequence supports consistent experimental results Commonly used in cellbased and tissuefocused research models where structural integrity, barrier function, or injuryrelated responses are endpoints Stable under recommended storage conditions Compatible with standard laboratory peptide handling protocols Verified for identity and consistency using routine quality-control techniques How BPC-157 (10 mg) Supports Research In research settings, BPC-157 is used to study peptide-driven cellular communication and signaling
Preserves peptide stability
Approximate stability guidelines for Glow Stack peptides under various storage conditions
